Midkine is a serum and urinary biomarker for the detection and prognosis of non-small cell lung cancer.
about
Diagnostic accuracy of ELISA for detecting serum Midkine in cancer patients.Prognostic value of Midkine expression in patients with solid tumors: a systematic review and meta-analysis.The expression of HOXA13 in lung adenocarcinoma and its clinical significance: A study based on The Cancer Genome Atlas, Oncomine and reverse transcription-quantitative polymerase chain reaction.
P2860
Midkine is a serum and urinary biomarker for the detection and prognosis of non-small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Midkine is a serum and urinary ...... of non-small cell lung cancer.
@en
Midkine is a serum and urinary ...... of non-small cell lung cancer.
@nl
type
label
Midkine is a serum and urinary ...... of non-small cell lung cancer.
@en
Midkine is a serum and urinary ...... of non-small cell lung cancer.
@nl
prefLabel
Midkine is a serum and urinary ...... of non-small cell lung cancer.
@en
Midkine is a serum and urinary ...... of non-small cell lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
Midkine is a serum and urinary ...... of non-small cell lung cancer.
@en
P2093
Chun-Hua Su
Hong-He Luo
Jian-Jun Lu
Shui-Shen Zhang
P2860
P304
87462-87472
P356
10.18632/ONCOTARGET.13865
P407
P577
2016-12-10T00:00:00Z